Do you want to read an article? Please log in or register.
Optimizing tissue sampling during medical pleuroscopy for diagnosis of malignant pleural effusion due to lung cancer
Lung CancerPleural Diseases
Related content
COMMENTED
Pleural DiseasesPneumonia
The Impact of clinically significant pleural effusion on survival of US Veterans with cancer, congestive heart failure, and pneumonia: The Veterans Administration Lung Effusion Study (VALUES)
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Chest
Chopra A, Hu K, Gemoets DE, Judson MA
doi: 10.1016/j.chest.2025.02.003
RECOMMENDED
Lung Cancer
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Xenophontos E, Giaj Levra N, Durieux V, van Geffen WH, Grisay G, De la Pinta Alonso C, Arasanz H, Prisciandaro E, Ferrara R, Derks J, Von der Thusen J, Dickhoff C, Brandão M, Faivre-Finn C, Edwards J, Ruysscher D, Remon J, Dingemans AC, Berghmans T
doi: 10.1016/j.lungcan.2025.108671
RECOMMENDED
Pleural DiseasesFurther Publications
Mortality after treatment of malignant pleural effusions with indwelling pleural catheters versus chemical pleurodesis: a population-based study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Kwok C, Thavorn K, Amjadi K, Aaron SD, Kendzerska T
doi: 10.1186/s12931-024-03023-6
Lung Cancer
Prognostic impact of pleural lavage cytology in EGFR-stratified resected non-small cell lung cancer
Lung Cancer
Ishibashi N, Nagata H, Yabe R, Ueda K, Nonomura R, Oshima Y, Sasaki T, Niikawa H
doi: 10.1016/j.lungcan.2025.108804
RECOMMENDED
Lung Cancer
What is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (≥ 5 cm) Non-Small Cell Lung Cancer?
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer
Yoo YJ, Song SY, Shin YS, Kim SS
doi: 10.1016/j.cllc.2025.07.018
COMMENTED
Interstitial Lung Disease
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM
doi: 10.1183/13993003.02533-2024
Lung Cancer
MRD status combined with TNM staging optimizes postoperative prognostic stratification in non-small cell lung cancer: a meta-analysis and systematic review
Lung Cancer
Shi Y, Chen R, Xiong Y, Geng R, Guo C, Liu L, Chen Y, Wang Y
doi: 10.1016/j.lungcan.2025.108634
Lung Cancer
Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer
Clin Lung Cancer
Cao W, Duan H, Shao C, Yan X, Liu H
doi: 10.1016/j.cllc.2025.08.004
Lung Cancer
EBUS-TBNA for Diagnosis and Staging of Lung Cancer: A Retrospective Regional Analysis Integrating Clinical and Molecular Data (EXPoSURE Score)
J Clin Med
Andrei GM, Motaș N, Rădulescu VM, Ionovici N, Bunescu M, Zob DL, Biciușcă V, Dumitrescu F, Marcu EA, Cioboată R, Olteanu M
doi: 10.3390/jcm14176179